Skip to main content

Table 3 Clinical results

From: Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting

Year

Tamsulosin monotherapy (SoC)

Tamsulosin monotherapy & gradual introduction of DUT + TAM FDC

Number avoided

 

TURP

AUR episodes

TURP

AUR episodes

TURPS

AUR episodes

1

7,145

5,786

7,102

5,726

42

60

2

12,507

6,366

12,147

6,198

360

168

3

9,637

5,943

9,215

5,702

422

241

4

11,475

7,183

10,541

6,679

934

503

Total

40,763

25,277

39,006

24,305

1,758

942